Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00908167
Title Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

bone marrow cancer

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Clofarabine + Cytarabine + Sorafenib

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.